|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/32 | |||
| A61P 35/00 | |||
| A61K 39/395 |
| (11) | Number of the document | 2943508 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14700281.0 |
| Date of filing the European patent application | 2014-01-10 | |
| (97) | Date of publication of the European application | 2015-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/050344 |
| Date | 2014-01-10 |
| (87) | Number | WO 2014/108484 |
| Date | 2014-07-17 |
| (30) | Number | Date | Country code |
| 13151076 | 2013-01-11 | EP |
| (72) |
BAUSS, Frieder, DE
BOSSENMAIER, Birgit, DE
FRIESS, Thomas, DE
GERDES, Christian, AR
HASMANN, Max, DE
THOMAS, Marlene, DE
WEISSER, Martin, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTI-HER3 AND ANTI-HER2 ANTIBODIES |
| COMBINATION THERAPY OF ANTI-HER3 AND ANTI-HER2 ANTIBODIES |